TECOGEN INC.·4

Jun 30, 8:33 PM ET

ALBERTINE JOHN M 4

4 · TECOGEN INC. · Filed Jun 30, 2026

Research Summary

AI-generated summary of this filing

Updated

TecoGen (TGEN) Director John M. Albertine Receives 25,000-Share Award

What Happened
John M. Albertine, a director of TecoGen Inc. (TGEN), was granted 25,000 shares as an award/acquisition on June 26, 2026. The filing lists an acquisition price of $5.17 per share, giving a total value of $129,250. This was an award/derivative grant (not an open‑market purchase or sale).

Key Details

  • Transaction date: 2026-06-26
  • Transaction type: Award/Grant (derivative acquisition) — 25,000 shares at $5.17 per share; total value $129,250
  • Vesting: Vests 25% per year (footnote) — implies a four-year vesting schedule before full ownership/transferability
  • Shares owned after transaction: Not reported in the Form 4 filing
  • Filing timeliness: No late filing indicator reported

Context
This was a derivative award subject to a multi-year vesting schedule, meaning the shares are not fully vested or immediately tradable. Awards like this are routine for directors and compensate service; they are recorded as acquisitions on Form 4 but do not necessarily reflect immediate market activity.

Insider Transaction Report

Form 4
Period: 2026-06-26
Transactions
  • Award

    Stock Option (Right to Buy)

    [F1]
    2026-06-26$5.17/sh+25,000$129,25025,000 total
    Exercise: $5.17From: 2027-06-26Exp: 2036-06-26Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]Vests 25% per year
Signature
/s/ John M. Albertine|2026-06-30

Documents

1 file
  • 4
    wk-form4_1782866000.xmlPrimary

    FORM 4